Form 3 ARROWHEAD PHARMACEUTICAL For: Feb 06 Filed by: INGRAM DOUGLAS S

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Form 3 ARROWHEAD PHARMACEUTICAL For: Feb 06 Filed by: INGRAM DOUGLAS S

Chardan Capital Markets Reiterates Buy Rating on Arrowhead Pharma (ARWR)

February 11, 2025 7:46 AM EST

Chardan Capital Markets analyst Keay Nakae reiterated a Buy rating and $60.00 price target on Arrowhead Pharma (NASDAQ: ARWR)

The analyst comments "The company is currently evaluating plozasiran in three other phase III studies: SHASTA-3 and SHASTA-4 in adults with SHTG (currently enrolling), and MUIR-3 in adults... More